Last reviewed · How we verify
DFDBA with atorvastatin
DFDBA (demineralized freeze-dried bone allograft) combined with atorvastatin promotes bone regeneration and reduces inflammation in periodontal and dental defects.
DFDBA (demineralized freeze-dried bone allograft) combined with atorvastatin promotes bone regeneration and reduces inflammation in periodontal and dental defects. Used for Periodontal bone defects and regeneration, Alveolar bone loss associated with periodontitis, Dental implant site augmentation.
At a glance
| Generic name | DFDBA with atorvastatin |
|---|---|
| Also known as | atorvastatin gel |
| Sponsor | Kamineni Institute of Dental Sciences |
| Drug class | Bone graft material with adjunctive pharmaceutical agent |
| Modality | Small molecule |
| Therapeutic area | Dentistry / Periodontics / Oral Surgery |
| Phase | FDA-approved |
Mechanism of action
DFDBA is an allograft material that provides a scaffold for bone formation and contains osteoinductive proteins that stimulate new bone growth. Atorvastatin, a statin, enhances osteoblast differentiation and bone formation while reducing inflammatory markers, synergistically improving bone regeneration outcomes in dental applications.
Approved indications
- Periodontal bone defects and regeneration
- Alveolar bone loss associated with periodontitis
- Dental implant site augmentation
Common side effects
- Infection at graft site
- Graft rejection or resorption
- Swelling or edema
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DFDBA with atorvastatin CI brief — competitive landscape report
- DFDBA with atorvastatin updates RSS · CI watch RSS
- Kamineni Institute of Dental Sciences portfolio CI